BRAF and MEK inhibitors and their toxicities: a meta-analysis
These drugs are all glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
The authors determined significantly higher concentrations of semaglutide in the hypothalamus compared to other parts of the brain, indicating that the drug effectively reaches regions associated with the GLP-1 receptor, which are related to appetite suppression and neuroprotection
We know that a heavy toxic burden puts you at greater risk of developing an autoimmune disease
Through partnerships that include Augusta Universitys Medical College of Georgia, Wellstar helps educate future clinicians, accelerate discovery and translate research into real-world impact
Learn More Nootropic peptides that cross the blood-brain barrier to enhance memory formation, focus, mood stability, and deep sleep without stimulant side effects